|
General Publications
|
|
|
|
|

|
|
High density Cell Culture in a new passive membrane
based bioreactor
|
|
M. Wolf, T. DeSutter; Biotechnology
International 1999
|
|
| Celline Overview, Application Introduction
This report is an overview of the CELLine regarding its operation
and the principle of cell compartment viable cell capacity. This
report describes the impact of nutrient medium exchange
and the diffusion of solute across the semi permeable
membrane. The importance of inoculation density and
its impact on culture initiation is described. The variable volume
of the cell compartment, expected osmotic water flux, and equivalency
between the different CELLine models is also reported. >more
|
|
M. Wolf; Wilson Wolf Corporation,
Minneapolis USA
|

|
|
|
|
|
|
|
Antibody Expression in Hybridoma
|
|

|
|
Dialysis-based bioreactor systems for the production
of mono-clonal antibodies - alternatives to
ascites production in mice
|
|
M.P. Bruce, V. Boyd, C. Duch, J.R. White; Journal of Immunological
Methods 2002, 264: 59-68
|
|
|
Manufacture of Pure Monoclonal Antibodies by Heterogeneous
Culture without Downstream Purification
|
|
L.E. Scott, H. Aggett,
D.K. Glencross; Biotechniques 2001, 31-3: 666-68
|
|
|
Efficient laboratory-scale production of monoclonal
antibodies using membrane-based high density
cell culture technology
>more
|
|
M. Trebak, J.M. Chong, D. Herlyn, D.W. Speicher; Journal
of Immunological
Methods 1999, 230: 59-70
|

|
|
Comparison
of batch vs. Celline culture for production
of mono-clonal antibody in vitro as alternatives
to ascites. Application: Murine Hybridoma
This report is a comparison of antibody production
in the CELLine relative to a traditional batch culture
method. The seven hybridoma clones which were cultured
in the CELLine had been previously cultured using a traditional
batch method. Comparison of results obtained in the CELLine
and in batch culture is provided. The benefits of a concentrated
product, reduced handling, and reduced serum use are demonstrated.
The consumption of nutrient medium by the two different
methods is reported and provided for each clone.>more
|
|
M. Wolf; Wilson Wolf Corporation,
Minneapolis USA
|

|
|
Antibody Manufacture in the Celline CL1000,
Application: Murine hybridoma
This report includes results from the culture
of over 30 different hybridoma clones in the
CELLine. The results from the large number of
different clones provides a range of performance
which the user can use to compare their individual
results. Mean target values for cell numbers,
antibody yield and harvest times and volume
are provided derived from cultures of different
hybridoma clones. Importantly, the clones were
randomly selected representing numerous mAb
isotypes and fusion partners. Additionally,
all the cultures were carried out in a small
manufacturing environment aimed towards reducing
overall costs and labor.>more
|
|
M. Wolf; Wilson Wolf Corporation,
Minneapolis USA
|

|
|
Attachment
dependent cell cultivation on Micro-Carriers: Secreted protein production >more
|
|
M. Wolf; Wilson Wolf Corporation,
Minneapolis USA
|

|
|
Membrane-based cell culture systems - an alternative
to in Vivo production of monoclonal antibodies
A new generation
of membrane based cell culture devices tailored
to small scale production of
monoclonal antibodies (mab´s) entered
the market in last few years. In contrast to
conventional perfusion hollow fiber bioreactors,
these devices contain two functionally different
membranes - one dialysis membrane for nutrient
supply and one gas permeable membrane for direct
oxygenation of cells. The latest systems of
this generation are static culture systems of
moderate costs and either better than, or equal
to, the ascites mice in terms of quality and
quantity of produced monoclonal antibodies.
We have investigated the advantages of the perfused
Tecnomouse bioreactor and the static CELLine
culture flasks in comparison to ascites production
and conventional roller bottle cultures.>more
|
|
A. Nagel, S. Koch, U. Valley,
F. Emmrich, U. Marx; Dev Biol Stand 1999, 101: 57-64
|

|
|
Rapid evaluation of hybridoma behaviour in high
cell density pro-duction process
|
|
S. Koch, A. Kriszo, C. Kloth, U. Marx, A. Nagel; ESACT
1999, Lugano 1999
|
|
|
Membrane-based cell culture
technologies: a scientifically and economically
satisfactory alternative to malignant ascites
production for monoclonal antibodies
|
|
U. Marx; Res Immunol 1998, 149: 557-9
|
|
|
Protein expression in CHO cells
|
|
|
|
|

|
|
A soluble TGF-b type-1 Receptor mimics TGFb responses
|
|
F. Docagne, N. Colloc'h, V. Bougueret, M. Page, J. Paput,
M. Tripier, P. Dutartre,
E.T. MacKenzie, A. Buisson, S. Komesli, D. Vivien; Journal of Biological
Chemistry
2001, 276-49: 46243-50
|
|
|
High density suspension culture for Recombinant
Protein produc-tion from CHO cells >more
|
|
M. Wolf; Wilson Wolf Corporation,
Minneapolis USA
|

|
|
|
|
|
|
|
Protein expression in BHK cells
|
|
|
|
|

|
|
Long-Term High Level Protein Expression in Adherent,
Protein-free Growing BHK Cells Using INTEGRA
CELLine adhere 1000 Bio-reactor
Flasks
|
|
J. Mittermaier, M. O. Zang-Gandor; EUGENEX Biotechnologies
GmbH,
Tägerwilen, Switzerland
|

|
|
Protein expression in 293 cells
|
|
|
|
|

|
|
Improved Method of Utilizing Transient Transfections
in HEK293E Cells for Small Scale Antibody
Production
|
|
Masahisa Handa, Eddie Bautista, Peter Wong, Robyn Cotter,
Lynn Webster, Arnold Horwitz
|

|
|
Mulit-Milligram Production of Antibodies Using
Transiently Transfected HEK293 Cells Cultured
in Integra Flasks
|
|
Eddie Bautista, Masahisa Handa
|

|
|
Production in Baculovirus Infected SF9 Cells
|
|
|
|
|

|
|
Continuous Recombinant Protein Production in Baculovirus
Infected SF9 Cells using CELLine classic
1000 Two-Compartment Bioreactors
|
|
Izumi Matsumoto (GSI Creos GmbH, Tokio, Japan) and Alex
Studer (INTEGRA Biosciences, Chur, Switzerland)
|

|
|
Fermentation
|
|
|
|
|

|
|
The Application of in vitro Models for Production
of Metabolites: Isolation and Characterisation
of Hydroxysecobarbital
|
|
D. Marshall, M. Robinson, P. Hincks, M. Dumasia, P. Teale,
E. Houghton; hromatographia
Supplement 2000, 52: 35-38
|
|
|
Protein production in plant cells
|
|
|
|
|

|
|
Production of Human alpha-1-Antitrypsin from Transgenic
Rice Cell Culture in a Membrane Bioreactor
|
|
McDonald KA et al. 2005,
21: 728-34
|
|